215 related articles for article (PubMed ID: 31846126)
1. Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.
Farrand E; Vittinghoff E; Ley B; Butte AJ; Collard HR
Respirology; 2020 Jun; 25(6):629-635. PubMed ID: 31846126
[TBL] [Abstract][Full Text] [Related]
2. Pulse versus non-pulse corticosteroid therapy in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Hyung K; Lee JH; Kim JY; Choi SM; Park J
Respirology; 2024 Mar; 29(3):235-242. PubMed ID: 38087838
[TBL] [Abstract][Full Text] [Related]
3. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
4. Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Anan K; Kataoka Y; Ichikado K; Kawamura K; Johkoh T; Fujimoto K; Tobino K; Tachikawa R; Ito H; Nakamura T; Kishaba T; Inomata M; Kamitani T; Yamazaki H; Ogawa Y; Yamamoto Y
Respir Res; 2022 Oct; 23(1):291. PubMed ID: 36289512
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and Outcomes of a Standardized Management Protocol for Acute Exacerbation of Interstitial Lung Disease.
Adams CJ; Chohan K; Rozenberg D; Kavanagh J; Greyling G; Shapera S; Fisher JH
Lung; 2021 Aug; 199(4):379-387. PubMed ID: 34347146
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?
Cuerpo S; Moisés J; Hernández-González F; Benegas M; Ramirez J; Sánchez M; Agustí À; Sellares J
Chron Respir Dis; 2019; 16():1479973119869334. PubMed ID: 31431063
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department.
Jang HJ; Yong SH; Leem AY; Lee SH; Kim SY; Lee SH; Kim EY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
Sci Rep; 2021 Mar; 11(1):5762. PubMed ID: 33707643
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
9. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
[TBL] [Abstract][Full Text] [Related]
10. Initial therapeutic dose of corticosteroid for an acute exacerbation of IPF is associated with subsequent early recurrence of another exacerbation.
Yamazaki R; Nishiyama O; Saeki S; Sano H; Iwanaga T; Tohda Y
Sci Rep; 2021 Mar; 11(1):5782. PubMed ID: 33707613
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Hozumi H; Hasegawa H; Miyashita K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Respirology; 2019 Aug; 24(8):792-798. PubMed ID: 30803100
[TBL] [Abstract][Full Text] [Related]
12. Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience.
Kawamura K; Ichikado K; Ichiyasu H; Anan K; Yasuda Y; Suga M; Sakagami T
BMC Pulm Med; 2019 Jun; 19(1):113. PubMed ID: 31238929
[TBL] [Abstract][Full Text] [Related]
13. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
Richeldi L
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
Furuya K; Sakamoto S; Shimizu H; Sekiya M; Kinoshita A; Isshiki T; Sugino K; Matsumoto K; Homma S
Respir Med; 2017 May; 126():93-99. PubMed ID: 28427556
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis.
Rangappa P; Moran JL
Crit Care Resusc; 2009 Jun; 11(2):102-9. PubMed ID: 19485873
[TBL] [Abstract][Full Text] [Related]
16. Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis.
Kishaba T; Tamaki H; Shimaoka Y; Fukuyama H; Yamashiro S
Lung; 2014 Feb; 192(1):141-9. PubMed ID: 24221341
[TBL] [Abstract][Full Text] [Related]
17. Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis.
Oishi K; Aoe K; Mimura Y; Murata Y; Sakamoto K; Koutoku W; Matsumoto T; Ueoka H; Yano M
Intern Med; 2016; 55(24):3551-3559. PubMed ID: 27980253
[TBL] [Abstract][Full Text] [Related]
18. Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis.
Oda K; Ishimoto H; Yamada S; Kushima H; Ishii H; Imanaga T; Harada T; Ishimatsu Y; Matsumoto N; Naito K; Yatera K; Nakazato M; Kadota J; Watanabe K; Kohno S; Mukae H
Respir Res; 2014 Sep; 15(1):109. PubMed ID: 25176016
[TBL] [Abstract][Full Text] [Related]
19. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
[TBL] [Abstract][Full Text] [Related]
20. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]